youtube_live
Zarada za Q3 2026 • objavljeno • EPS je podbacio −53,77% • Prihod je premašen +0,50%
Pogledajte rezultatechevron_right
FME:ETR
Fresenius Medical Care
42,23 €
arrow_downward
−0,21%(−0,090) 1D
6. stu, 17:36:28 GMT+1 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za FME...
Otvori
42,59 €
Najviša
42,60 €
Najniža
41,50 €
Trž. kap.
11,36 mlr.
Prosj. kol.
988,42 tis.
Količina
1,26 mil.
Dividenda
3,53 %
Kvartalna dividenda
0,37 €
Datum nakon isplate dividende
22. svi 2026.
P/E omjer
14,11
52-tjed. najviša
45,90 €
52-tjed. najniža
34,57 €
EPS
2,99 €
Dionice u optjecaju
268,56 mil.
Broj djelatnika
106 tis.
Otvori
42,59 €
Najviša
42,60 €
Najniža
41,50 €
Trž. kap.
11,36 mlr.
Prosj. kol.
988,42 tis.
Količina
1,26 mil.
Dividenda
3,53 %
Kvartalna dividenda
0,37 €
Datum nakon isplate dividende
22. svi 2026.
P/E omjer
14,11
52-tjed. najviša
45,90 €
52-tjed. najniža
34,57 €
EPS
2,99 €
Dionice u optjecaju
268,56 mil.
Broj djelatnika
106 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
VZ VermögensZentrum
·
prije 20 sati
Fresenius Medical Care sees 2026 operating income flat to down mid-single digits
GuruFocus
·
prije 21 sat
Fresenius Medical Care AG (FMS) (Q3 2026) Earnings Call Highligh
Yahoo Finance
·
prije 2 dana
Fresenius Medical Care AG (FMS) Stock Forecasts
Investing.com Canada
·
prije 2 dana
Earnings call transcript: Fresenius lifts 2026 outlook after strong Q3 results
Profil
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives.
With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan.
The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue.
As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
Fresenius Medical Care – informacije
Glavni izvršni direktorHelen Giza
Zaposlenici106 tis.
Osnovano1996
Sjedište-
SektorHealth Care
DjelatnostHealth care provider
Web-lokacijafreseniusmedicalcare.com